Abstract:Objective. In order to find the best process for the preparation of Chrysophanol-Pluronic F127 nanomicelles in the laboratory, the preparation of Chrysophanol-Pluronic F127 nanomicelles was optimized using the central composite design method. In order to investigate the properties of the prepared Chrysophanol-Pluronic F127 nanomicelles, physicochemical properties were examined and in vitro dissolution experiments were performed, and the pharmacokinetics of Chrysophanol and Chrysophanol-Pluronic F127 nanomicelles were investigated in rabbits. Methods. In the preexperimental study, the best physical solubilization method and organic solvent for Chrysophanol were selected. The ratio of drug dosage to excipient dosage and the amount of organic solvents were evaluated by single-factor test. Based on the single-factor test, the optimal prescription was obtained by screening the formulation and optimizing the preparation process using the central composite design method with the encapsulation efficiency as the index. Chrysophanol-Pluronic F127 nanomicelles were prepared according to the optimal prescription, and their particle size, potential, appearance, and in vitro release experiments were carried out. Chrysophanol and Chrysophanol-Pluronic F127 nanomicelles were injected intravenously through the ear margins to rabbits, and the drug concentrations in the blood were measured at different time points by HPLC. The obtained blood concentration data were fitted with PK Solver 2.0 program to obtain pharmacokinetic parameters. Results. In the preexperimental study, ultrasonic method was selected as the physical solubilization method, and acetone was selected as the organic solvent. In single-factor test, the highest encapsulation efficiency was achieved when the ratio of drug dosage to excipient dosage was 1 : 15; the highest encapsulation efficiency was achieved when the amount of organic solvent (acetone) was 8 mL. The equation fitted to the model for the optimized prescription by the central composite design method is as follows: R 1 = − 166.93629 + 16.86478 A + 32.55582 B − 0.169750 AB − 0.482675 2 − 2.25797 B 2 R 2 = 0.9457 . The best prescription for the preparation of Chrysophanol-Pluronic F127 nanomicelles was obtained in the ratio of drug dosage to excipient dosage of 1 : 16.309 and the dosage of organic solvent was 6.595 mL. The prepared nanomicelles have a particle size of 152.8 nm and a potential of -23.9 mV. It was observed by transmission electron microscope that the prepared nanomicelles are uniform and spherical in appearance. The drug metabolism of Chrysophanol and nanomicelles in rabbits conforms to the two-compartment open model, and both of them show linear kinetics in the drug dose range. T 1 / 2 α was 0.31 ± 0.21 h and 0.47 ± 0.35 -Abstract Truncated-

Multi-Variable Regression Analysis Applied to Synchronously Optimize Preparation of Nanoparticles

Two modelling data analytical methods applied to optimise the preparation of norcantharidin chitosan nanoparticles

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Response surface methodology for the optimization of lactoferrin nano-liposomes

Application of Pharmacodynamics-Based Optimization to the Extraction of Bioactive Compounds from Chansu

Preparation and optimization of glyceryl monooleate-low molecular weight chitosan nanoparticles for delivery of morpholinopyrrolizine derivative

Formulation optimization of scutellarin-loaded HP-β-CD/chitosan nanoparticles using response surface methodology with Box–Behnken design

Preparation of chitosan nanoparticles by ionotropic gelation technique: Effects of formulation parameters and in vitro characterization

An Optimization Method for Extraction Process of Coptis Chinensis with Uniform Design and Regression Analysis

Optimizing the preparatory conditions of nano particle photocatalyst ZnO/SnO2 coupled oxide based on the methods of experimental design and modeling

Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box–Behnken Experimental Design

Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology

Study on Central Composite Design Method to Optimize the Preparation Process of Chrysophanol-Pluronic F127 Nanomicelles and Pharmacokinetics

Application of Central Composite Design-Based Response Surface Methodology in Optimization of the Preparation Process of Sanguinarine Chitosan Microspheres

Preparation and Optimization of Resveratrol Nanosuspensions by Antisolvent Precipitation Using Box-Behnken Design

Analysis of nanonization and purification of organic compounds via green supercritical processing: Model development using advanced hybrid techniques

Development and analysis of machine-learning guided flash nanoprecipitation (FNP) for continuous chitosan nanoparticles production

Stepwise multiple regressions application in liposome orthogonal experiments

Application of the Non-dominated Sorting Genetic Algorithm II in Multi-objective Optimization of Orally Disintegrating Tablet Formulation

Interpretable Causal System Optimization Framework for the Advancement of Biological Effect Prediction and Redesign of Nanoparticles

Development of a Curcumin-Loaded Lecithin/Chitosan Nanoparticle Utilizing a Box-Behnken Design of Experiment: Formulation Design and Influence of Process Parameters